The diverse marketed formulations of advanced nano drug carrier vehicles (and CVS) in different biomedical treatments: a complete descriptive review

Abstract

The field of pharmaceutical science and drug delivery
has seen a remarkable transformation in recent years, marked by the
emergence of diverse advanced approaches in the development of
Novel Drug Delivery Systems (NDDs) and their associated carriers.
Nanocarriers are tiny particles that can be used to deliver drugs to the
body. They are typically less than 100 nanometres in diameter, which
is about 1,000 times smaller than the width of a human hair. NDDs
play a pivotal role in enhancing the therapeutic efficacy, safety, and
patient compliance of pharmaceuticals. The research community has
increasingly focused on creating novel drug delivery systems to
address the limitations of conventional drug administration methods.
The diversification of these approaches is notable, reflecting the
interdisciplinary nature of pharmaceutical sciences. NDDs can be
used to deliver drugs to specific sites in the body, control the rate of
drug release, and protect drugs from degradation. Carriers play an
important role in NDDs. The main highlights of the review articles
in to focus on the diverse nano drug carriers including niosome,
liposome, aquasome, nanoparticles (NPs) and phytosomes with their
marketed available different products with their specified disease
targeting.